Poolbeg Pharma Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Jeremy Skillington
Chief executive officer
UK£362.0k
Total compensation
| CEO salary percentage | 69.1% |
| CEO tenure | 3.3yrs |
| CEO ownership | 0.2% |
| Management average tenure | less than a year |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£4m |
| Mar 31 2024 | n/a | n/a | -UK£4m |
| Dec 31 2023 | UK£362k | UK£250k | -UK£4m |
| Sep 30 2023 | n/a | n/a | -UK£4m |
| Jun 30 2023 | n/a | n/a | -UK£5m |
| Mar 31 2023 | n/a | n/a | -UK£5m |
| Dec 31 2022 | UK£310k | UK£250k | -UK£5m |
| Dec 31 2021 | UK£261k | n/a | -UK£3m |
Compensation vs Market: Jeremy's total compensation ($USD454.60K) is about average for companies of similar size in the German market ($USD472.15K).
Compensation vs Earnings: Jeremy's compensation has increased whilst the company is unprofitable.
CEO
Jeremy Skillington (53 yo)
3.3yrs
Tenure
UK£362,000
Compensation
Dr. Jeremy Skillington, Ph D., serves as Chief Executive Officer and since July 19, 2021 as Director at Poolbeg Pharma PLC. He is Vice President of Business Development at Inflazome Ltd.Dr. Skillington se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of The Board | 3.7yrs | UK£150.00k | 4.36% € 1.9m | |
| CEO & Director | no data | UK£362.00k | 0.17% € 75.9k | |
| CFO & Director | no data | UK£237.00k | 1.67% € 723.6k | |
| Vice President of Investor Relations & Public Relations | 1.8yrs | no data | no data | |
| Senior Vice President & Chief Legal Officer | less than a year | no data | no data | |
| Chief Business Officer | less than a year | no data | no data | |
| Group Financial Controller | no data | no data | no data |
0.9yrs
Average Tenure
53.5yo
Average Age
Experienced Management: 7JN's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of The Board | 3.7yrs | UK£150.00k | 4.36% € 1.9m | |
| CEO & Director | 3.3yrs | UK£362.00k | 0.17% € 75.9k | |
| CFO & Director | 3.5yrs | UK£237.00k | 1.67% € 723.6k | |
| Independent Non-Executive Director & Member of Scientific Advisory Board | 3.3yrs | UK£40.00k | no data | |
| Member of Scientific Advisory Board & Independent Non Executive Director | 1.9yrs | UK£24.00k | 0.53% € 228.7k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Senior Independent Director | 3.3yrs | UK£35.00k | no data | |
| Member of Scientific Advisory Board | 3yrs | no data | no data |
3.3yrs
Average Tenure
60yo
Average Age
Experienced Board: 7JN's board of directors are considered experienced (3.3 years average tenure).